Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Total Current Liabilities came in at $963.7 million in Q2 2026, up 2.27% on a YoY basis from $942.3 million in Q2 2025, and up 3.72% quarter-over-quarter from $929.1 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Total Current Liabilities for 5 consecutive years, with $963.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 2.27% year-over-year to $963.7 million; the trailing twelve-month figure through Jun 2026 stood at $963.7 million (up 2.27% YoY), and the FY2025 full-year result was $913.3 million, down 3.81% from the prior year.
- Total Current Liabilities grew to $963.7 million in Q2 2026 per FTRE's latest filing, from $929.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $999.1 million in Q1 2025 and bottomed at $699.0 million in Q4 2022.
- Historically, Total Current Liabilities has averaged $855.6 million across 5 years, with a median of $865.8 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities grew 25.81% in 2025, then dropped 7.01% in 2026.
- Over 5 years, Total Current Liabilities stood at $699.0 million in 2022, then gained by 11.36% to $778.4 million in 2023, then rose by 21.98% to $949.5 million in 2024, then slipped by 3.81% to $913.3 million in 2025, then gained by 5.52% to $963.7 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $963.7 million, $929.1 million, and $913.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 1.13 Bn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 3.93 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 19.92 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 4.22 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 963.70 Mn |
| Mar 31, 2026 | 929.10 Mn |
| Dec 31, 2025 | 913.30 Mn |
| Sep 30, 2025 | 914.40 Mn |
| Jun 30, 2025 | 942.30 Mn |
| Mar 31, 2025 | 999.10 Mn |
| Dec 31, 2024 | 949.50 Mn |
| Sep 30, 2024 | 795.80 Mn |
| Jun 30, 2024 | 749.00 Mn |
| Mar 31, 2024 | 818.30 Mn |
| Dec 31, 2023 | 778.40 Mn |
| Sep 30, 2023 | 774.60 Mn |
| Jun 30, 2023 | 752.10 Mn |
| Dec 31, 2022 | 699.00 Mn |